Growth Metrics

ADC Therapeutics (ADCT) Change in Inventory: 2021-2023

Historic Change in Inventory for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2023 value amounting to -$167,000.

  • ADC Therapeutics' Change in Inventory fell 101.73% to -$167,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year decrease of 40.81%. This contributed to the annual value of $3.7 million for FY2024, which is 34.73% down from last year.
  • As of Q4 2023, ADC Therapeutics' Change in Inventory stood at -$167,000, which was down 104.80% from $3.5 million recorded in Q3 2023.
  • ADC Therapeutics' 5-year Change in Inventory high stood at $9.7 million for Q4 2022, and its period low was -$3.0 million during Q4 2021.
  • Over the past 3 years, ADC Therapeutics' median Change in Inventory value was -$174 (recorded in 2021), while the average stood at $1.2 million.
  • As far as peak fluctuations go, ADC Therapeutics' Change in Inventory plummeted by 26,714.29% in 2022, and later spiked by 186,841.81% in 2023.
  • Quarterly analysis of 3 years shows ADC Therapeutics' Change in Inventory stood at -$3.0 million in 2021, then skyrocketed by 419.66% to $9.7 million in 2022, then crashed by 101.73% to -$167,000 in 2023.
  • Its last three reported values are -$167,000 in Q4 2023, $3.5 million for Q3 2023, and $2.1 million during Q2 2023.